Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
22.50
+1.67 (8.02%)
May 6, 2026, 11:44 AM EDT - Market open

Pediatrix Medical Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9321,9142,0131,9951,9721,911
Revenue Growth (YoY)
-2.25%-4.92%0.92%1.15%3.18%10.22%
Cost of Revenue
1,4281,4201,5591,5731,5051,398
Gross Profit
504.03493.7454.34421.57467.03513.24
Selling, General & Admin
242.45240.79238.44227.54231.4263.36
Depreciation & Amortization Expenses
22.6121.8332.2336.1735.6432.15
Other Operating Expenses
20.5922.27252.39150.5327.310.29
Total Operating Expenses
285.66284.89523.06414.24294.35295.79
Operating Income
218.37208.81-68.717.32172.69217.45
Interest Income
43.8943.588.126.45.3915.56
Interest Expense
-35.08-35.97-40.74-42.08-39.7-68.72
Other Non-Operating Income (Expense)
----20-57.021.91
Total Non-Operating Income (Expense)
8.827.62-32.63-55.68-91.32-51.25
Pretax Income
227.19216.43-101.34-48.3681.37166.2
Provision for Income Taxes
52.9651.04-2.2712.0518.8127.24
Net Income
174.22165.39-99.07-60.4166.34130.96
Minority Interest in Earnings
----00.03
Earnings From Discontinued Operations
----3.7722.95
Net Income to Common
174.22165.39-99.07-60.4166.34130.96
Net Income Growth
-----49.35%-
Shares Outstanding (Basic)
848483828385
Shares Outstanding (Diluted)
858583828486
Shares Change (YoY)
0.06%2.33%1.37%-2.28%-1.99%2.92%
EPS (Basic)
2.081.97-1.19-0.730.751.54
EPS (Diluted)
2.061.94-1.19-0.730.741.53
EPS Growth
-----51.63%-
Shares Outstanding
82.0682.9885.8784.0282.9586.42
Free Cash Flow
237.32252.63184.55104137.2344.49
Free Cash Flow Growth
-6.06%36.89%77.46%-24.22%208.46%-74.70%
Free Cash Flow Per Share
2.802.962.211.271.630.52
Gross Margin
26.09%25.80%22.57%21.13%23.68%26.85%
Operating Margin
11.30%10.91%-3.41%0.37%8.76%11.38%
Profit Margin
9.02%8.64%-4.92%-3.03%3.36%6.85%
FCF Margin
12.29%13.20%9.17%5.21%6.96%2.33%
EBITDA
240.98230.64-36.4943.49208.32249.6
EBITDA Margin
12.48%12.05%-1.81%2.18%10.56%13.06%
EBIT
218.37208.81-68.717.32172.69217.45
EBIT Margin
11.30%10.91%-3.41%0.37%8.76%11.38%
Effective Tax Rate
23.31%23.58%2.24%-24.92%23.11%16.39%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q